INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 44 filers reported holding INSMED INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -99.8% | 6,000 | -99.8% | 0.00% | – |
| Q1 2021 | $3,031,000 | +18.0% | 2,723,000 | +19.0% | 0.00% | – |
| Q4 2020 | $2,568,000 | +31.1% | 2,288,000 | +26.8% | 0.00% | – |
| Q3 2020 | $1,959,000 | +24.8% | 1,805,000 | +11.8% | 0.00% | – |
| Q2 2020 | $1,570,000 | +37.7% | 1,615,000 | +18.3% | 0.00% | – |
| Q1 2020 | $1,140,000 | +1.6% | 1,365,000 | +17.2% | 0.00% | – |
| Q4 2019 | $1,122,000 | +6.5% | 1,165,000 | -7.9% | 0.00% | – |
| Q3 2019 | $1,054,000 | +4.4% | 1,265,000 | +21.6% | 0.00% | – |
| Q2 2019 | $1,010,000 | -3.8% | 1,040,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,050,000 | +29.3% | 1,040,000 | -8.8% | 0.00% | – |
| Q4 2018 | $812,000 | +5.5% | 1,140,000 | +24.6% | 0.00% | – |
| Q3 2018 | $770,000 | +26.2% | 915,000 | +37.6% | 0.00% | – |
| Q2 2018 | $610,000 | -22.0% | 665,000 | -25.3% | 0.00% | – |
| Q1 2018 | $782,000 | – | 890,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |